Pharmacoeconomics (*****)
This document provides a wealth of information, listing a series of published journal articles in the application of pharmacoeonomics to numerous health topics. Some of the topics include strategies for the economic assessment during the development of new drugs and strategies for collecting pharmacoeconomic data during phase II/III clinical trials. Reprints of the articles can be requested by e-mail, fax, or mail.
Pharmacoeconomics (**)
This document provides a brief review of pharmacoeconomics, describing its use as a benchmark for practical authoritative reviews of the application of health economics to disease management outcomes and optimum drug therapy. However, it lacks detailed insight into the description of the overall concept and application of pharmacoeconomics to health care.
Pharmacoeconomics (**)
This document provides another resource of pharmacoeconomics, particularly describing the Institute of Pharmaco-Economics, located in Alberta, Canada. This description is a brief overview of the Institute which is a "unique consortium of academic, government, health industry, and other organizations concerned with the outcomes associated with the use of pharmaceutical products and other health care interventions". It does not provide a detailed description of the use of pharmacoeconomics to health care.
This is another resource providing on-line access to databases such as Medline. It does provide very brief abstracts of requested health topics. However, it requires a user registration, and may not be "as free" as claimed. I tried to become a registered user, but had a very difficult time understanding the consent contract and agreement terms. As a result, this document is worthwhile for getting information on topics like pharmacoeconomics, only if you are willing to consent to its contract and agreement terms. I wasn’t.
This document provides a brief reference related to the "Developing Association of Pharmacoeconomics and Outcomes Research (APOR) Generally Agreed upon Pharmacoeconomic Principles" project. It also briefly describes pharmacoeconomics, but lacks any detail information into its use and application to health care. A great lead to understanding pharmacoeconomics, but short on substance and material.
| Note: The information below may contain additional relevant materials and documents. Some of the information may be duplicate. The evaluations depend on both the student doing the review and the information contained at the time of the review. Sites are subject to change! |